Literature DB >> 17347835

Efficacy of steroid pulse, plasmapheresis, and mizoribine in a patient with focal segmental glomerulosclerosis.

Tomoko Imaizumi1, Yukihiko Kawasaki, Hiromi Matsuura, Ayumi Matsumoto, Kei Takano, Kazuhide Suyama, Koichi Hashimoto, Hitoshi Suzuki, Mitsuaki Hosoya.   

Abstract

There have been few reports on successful treatment for focal segmental glomerulosclerosis (FSGS) complicated by leukoencephalopathy. We report the efficacy of the steroid pulse and mizoribine (MZB) combined with plasmapheresis (PP) for a case of FSGS with leukoencephalopathy induced by cyclosporine (CyA). The patient was a 4-year-old boy with FSGS who presented with steroid-resistant nephrotic syndrome (NS) and was treated with CyA. On the 7th day after starting CyA, he complained of one visual disorder, and hypertension and tonic convulsions were observed. Electroencephalography (EEG) revealed generalized slow waves, and magnetic resonance imaging (MRI) disclosed high signal intensity in the white matter. A diagnosis of leukoencephalopathy induced by CyA was made on the basis of these findings with the improvement in clinical manifestations upon discontinuation of CyA. We treated the patient with steroid pulse therapy and MZB combined with PP, and the proteinuria gradually decreased and only microscopic hematuria remained. We report that steroid pulse and MZB combined with PP may be an effective treatment in a patient with FSGS complicated by CyA-induced leukoencephalopathy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17347835     DOI: 10.1007/s00467-007-0461-y

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  12 in total

Review 1.  Primary focal segmental glomerulosclerosis.

Authors:  S M Korbet
Journal:  J Am Soc Nephrol       Date:  1998-07       Impact factor: 10.121

Review 2.  Treatment of focal segmental glomerulosclerosis.

Authors:  Alain Meyrier
Journal:  Expert Opin Pharmacother       Date:  2005-08       Impact factor: 3.889

3.  High-dose mizoribine therapy for childhood-onset frequently relapsing steroid-dependent nephrotic syndrome with cyclosporin nephrotoxicity.

Authors:  Yoshiyuki Ohtomo; Shu-ichiro Fujinaga; Masaru Takada; Hitohiko Murakami; Shunji Akashi; Toshiaki Shimizu; Kazunari Kaneko; Yuichiro Yamashiro
Journal:  Pediatr Nephrol       Date:  2005-08-20       Impact factor: 3.714

4.  Long-term plasmapheresis and protein A column treatment of recurrent FSGS.

Authors:  A Belson; P D Yorgin; A Y Al-Uzri; O Salvatierra; J Higgins; S R Alexander
Journal:  Pediatr Nephrol       Date:  2001-12       Impact factor: 3.714

5.  Mizoribine oral pulse therapy for steroid-dependent nephrotic syndrome.

Authors:  Yukihiko Kawasaki; Junzo Suzuki; Ai Takahashi; Masato Isome; Ruriko Nozawa; Hitoshi Suzuki
Journal:  Pediatr Nephrol       Date:  2004-10-21       Impact factor: 3.714

6.  A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome.

Authors:  K Yoshioka; Y Ohashi; T Sakai; H Ito; N Yoshikawa; H Nakamura; T Tanizawa; H Wada; S Maki
Journal:  Kidney Int       Date:  2000-07       Impact factor: 10.612

7.  Oral mizoribine pulse therapy for patients with steroid-resistant and frequently relapsing steroid-dependent nephrotic syndrome.

Authors:  Yukihiko Kawasaki; Mitsuaki Hosoya; Schogo Kobayashi; Shinichirou Ohara; Noriko Onishi; Ai Takahashi; Masato Isome; Hitoshi Suzuki
Journal:  Nephrol Dial Transplant       Date:  2005-07-19       Impact factor: 5.992

Review 8.  Primary focal segmental glomerulosclerosis: clinical course and response to therapy.

Authors:  S M Korbet; M M Schwartz; E J Lewis
Journal:  Am J Kidney Dis       Date:  1994-06       Impact factor: 8.860

9.  Focal segmental glomerulosclerosis with rapid decline in renal function ("malignant FSGS").

Authors:  C B Brown; J S Cameron; D R Turner; C Chantler; C S Ogg; D G Williams; M Bewick
Journal:  Clin Nephrol       Date:  1978-08       Impact factor: 0.975

10.  The long-term prognosis of patients with focal segmental glomerulosclerosis.

Authors:  J S Cameron; D R Turner; C S Ogg; C Chantler; D G Williams
Journal:  Clin Nephrol       Date:  1978-12       Impact factor: 0.975

View more
  4 in total

Review 1.  Optimal management of primary focal segmental glomerulosclerosis in adults.

Authors:  Séverine Beaudreuil; Hans Kristian Lorenzo; Michele Elias; Erika Nnang Obada; Bernard Charpentier; Antoine Durrbach
Journal:  Int J Nephrol Renovasc Dis       Date:  2017-05-10

Review 2.  Mizoribine: a new approach in the treatment of renal disease.

Authors:  Yukihiko Kawasaki
Journal:  Clin Dev Immunol       Date:  2009-12-13

Review 3.  Recent understanding on diagnosis and management of central nervous system vasculitis in children.

Authors:  Ludovico Iannetti; Roberta Zito; Simone Bruschi; Laura Papetti; Fiorenza Ulgiati; Francesco Nicita; Francesca Del Balzo; Alberto Spalice
Journal:  Clin Dev Immunol       Date:  2012-09-12

Review 4.  Recent Advances in Treatments of Primary Focal Segmental Glomerulosclerosis in Children.

Authors:  Kyoung Hee Han; Seong Heon Kim
Journal:  Biomed Res Int       Date:  2016-04-18       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.